|
|
|
|
AN ACT
|
|
|
|
|
relating to the prescription of low-THC cannabis for medical use by |
|
certain qualified physicians to patients with certain medical |
|
conditions. |
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
SECTION 1. Section 169.001, Occupations Code, is amended by |
|
adding Subdivisions (1-a) and (6) and amending Subdivision (3) to |
|
read as follows: |
|
(1-a) "Incurable neurodegenerative disease" means a |
|
disease designated as an incurable neurodegenerative disease by |
|
rule of the executive commissioner of the Health and Human Services |
|
Commission, adopted in consultation with the National Institutes of |
|
Health. |
|
(3) "Low-THC cannabis" means the plant Cannabis sativa |
|
L., and any part of that plant or any compound, manufacture, salt, |
|
derivative, mixture, preparation, resin, or oil of that plant that |
|
contains[:
|
|
[(A)] not more than 0.5 percent by weight of |
|
tetrahydrocannabinols[; and
|
|
[(B)
not less than 10 percent by weight of
|
|
cannabidiol]. |
|
(6) "Terminal cancer" means cancer that meets the |
|
criteria for a terminal illness, as defined by Section 1003.051, |
|
Health and Safety Code. |
|
SECTION 2. Chapter 169, Occupations Code, is amended by |
|
adding Section 169.0011 and amending Sections 169.002, 169.003, and |
|
169.004 to read as follows: |
|
Sec. 169.0011. PRESCRIPTION FOR MEDICAL USE. A reference |
|
in this chapter, Chapter 487, Health and Safety Code, or other law |
|
to a prescription for medical use or a prescription for low-THC |
|
cannabis means an entry in the compassionate-use registry |
|
established under Section 487.054, Health and Safety Code. |
|
Sec. 169.002. PHYSICIAN QUALIFIED TO PRESCRIBE LOW-THC |
|
CANNABIS TO PATIENTS WITH CERTAIN MEDICAL CONDITIONS. (a) Only a |
|
physician qualified with respect to a patient's particular medical |
|
condition as provided by this section may prescribe low-THC |
|
cannabis in accordance with this chapter to treat the applicable |
|
medical condition. |
|
(b) A physician is qualified to prescribe low-THC cannabis |
|
with respect to a patient's particular medical condition [to a
|
|
patient with intractable epilepsy] if the physician: |
|
(1) is licensed under this subtitle; |
|
(2) is board certified in a medical specialty relevant |
|
to the treatment of the patient's particular medical condition by a |
|
specialty board approved by the American Board of Medical |
|
Specialties or the Bureau of Osteopathic Specialists; and |
|
(3) dedicates a significant portion of clinical |
|
practice to the evaluation and treatment of the patient's |
|
particular medical condition [epilepsy; and
|
|
[(3) is certified:
|
|
[(A)
by the American Board of Psychiatry and
|
|
Neurology in:
|
|
[(i) epilepsy; or
|
|
[(ii)
neurology or neurology with special
|
|
qualification in child neurology and is otherwise qualified for the
|
|
examination for certification in epilepsy; or
|
|
[(B) in neurophysiology by:
|
|
[(i)
the American Board of Psychiatry and
|
|
Neurology; or
|
|
[(ii)
the American Board of Clinical
|
|
Neurophysiology]. |
|
Sec. 169.003. PRESCRIPTION OF LOW-THC CANNABIS. A |
|
physician described by Section 169.002 may prescribe low-THC |
|
cannabis to a patient [alleviate a patient's seizures] if: |
|
(1) the patient is a permanent resident of the state; |
|
(2) the physician complies with the registration |
|
requirements of Section 169.004; and |
|
(3) the physician certifies to the department that: |
|
(A) the patient is diagnosed with: |
|
(i) [intractable] epilepsy; |
|
(ii) a seizure disorder; |
|
(iii) multiple sclerosis; |
|
(iv) spasticity; |
|
(v) amyotrophic lateral sclerosis; |
|
(vi) autism; |
|
(vii) terminal cancer; or |
|
(viii) an incurable neurodegenerative |
|
disease; and |
|
(B) the physician determines the risk of the |
|
medical use of low-THC cannabis by the patient is reasonable in |
|
light of the potential benefit for the patient[; and
|
|
[(C)
a second physician qualified to prescribe
|
|
low-THC cannabis under Section 169.002 has concurred with the
|
|
determination under Paragraph (B), and the second physician's
|
|
concurrence is recorded in the patient's medical record]. |
|
Sec. 169.004. LOW-THC CANNABIS PRESCRIBER REGISTRATION. |
|
(a) Before a physician qualified to prescribe low-THC cannabis |
|
under Section 169.002 may prescribe or renew a prescription for |
|
low-THC cannabis for a patient under this chapter, the physician |
|
must register as the prescriber for that patient in the |
|
compassionate-use registry maintained by the department under |
|
Section 487.054, Health and Safety Code. The physician's |
|
registration must indicate: |
|
(1) the physician's name; |
|
(2) the patient's name and date of birth; |
|
(3) the dosage prescribed to the patient; |
|
(4) the means of administration ordered for the |
|
patient; and |
|
(5) the total amount of low-THC cannabis required to |
|
fill the patient's prescription. |
|
(b) The department may not publish the name of a physician |
|
registered under this section unless permission is expressly |
|
granted by the physician. |
|
SECTION 3. Section 169.001(2), Occupations Code, is |
|
repealed. |
|
SECTION 4. Not later than December 1, 2019, the executive |
|
commissioner of the Health and Human Services Commission, in |
|
consultation with the National Institutes of Health, shall adopt |
|
rules designating diseases as incurable neurodegenerative diseases |
|
for which patients may be prescribed low-THC cannabis for medical |
|
use under Chapter 169, Occupations Code, as amended by this Act. |
|
SECTION 5. This Act takes effect immediately if it receives |
|
a vote of two-thirds of all the members elected to each house, as |
|
provided by Section 39, Article III, Texas Constitution. If this |
|
Act does not receive the vote necessary for immediate effect, this |
|
Act takes effect September 1, 2019. |
|
|
|
______________________________ |
______________________________ |
|
President of the Senate |
Speaker of the House |
|
|
|
I certify that H.B. No. 3703 was passed by the House on May 8, |
|
2019, by the following vote: Yeas 133, Nays 10, 2 present, not |
|
voting; and that the House concurred in Senate amendments to H.B. |
|
No. 3703 on May 24, 2019, by the following vote: Yeas 136, Nays 5, |
|
1 present, not voting. |
|
|
|
______________________________ |
|
Chief Clerk of the House |
|
|
I certify that H.B. No. 3703 was passed by the Senate, with |
|
amendments, on May 22, 2019, by the following vote: Yeas 31, Nays |
|
0. |
|
|
|
______________________________ |
|
Secretary of the Senate |
|
APPROVED: __________________ |
|
Date |
|
|
|
__________________ |
|
Governor |